ATE306917T1 - Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäure - Google Patents
Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäureInfo
- Publication number
- ATE306917T1 ATE306917T1 AT01274674T AT01274674T ATE306917T1 AT E306917 T1 ATE306917 T1 AT E306917T1 AT 01274674 T AT01274674 T AT 01274674T AT 01274674 T AT01274674 T AT 01274674T AT E306917 T1 ATE306917 T1 AT E306917T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- ibuprofen
- isobutylphenyl
- arginine
- composition containing
- Prior art date
Links
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 abstract 5
- 239000004475 Arginine Substances 0.000 abstract 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/042894 WO2003039532A1 (en) | 2001-11-02 | 2001-11-02 | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306917T1 true ATE306917T1 (de) | 2005-11-15 |
Family
ID=21742977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01274674T ATE306917T1 (de) | 2001-11-02 | 2001-11-02 | Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäure |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1439830B1 (de) |
| JP (1) | JP5185488B2 (de) |
| KR (1) | KR100851679B1 (de) |
| CN (1) | CN1302771C (de) |
| AT (1) | ATE306917T1 (de) |
| AU (1) | AU2002224475B2 (de) |
| CA (1) | CA2462452C (de) |
| DE (1) | DE60114249T2 (de) |
| DK (1) | DK1439830T3 (de) |
| ES (1) | ES2253326T3 (de) |
| MX (1) | MXPA04004024A (de) |
| WO (1) | WO2003039532A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040132823A1 (en) * | 2001-11-02 | 2004-07-08 | Leo Pavliv | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| KR101019201B1 (ko) | 2008-01-30 | 2011-03-03 | 대화제약 주식회사 | 덱시부프로펜 알지닌염의 제조방법 |
| KR20140014350A (ko) | 2009-03-12 | 2014-02-06 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 정맥 내 투여용 이부프로펜의 투여 |
| US8735452B2 (en) * | 2009-07-15 | 2014-05-27 | Cumberland Pharmaceuticals Inc. | Treating patients with intravenous ibuprofen |
| US8871810B2 (en) | 2009-07-15 | 2014-10-28 | Cumberland Pharmaceuticals Inc. | Treating critically ill patients with intravenous ibuprofen |
| AU2009350474A1 (en) * | 2009-07-31 | 2012-03-01 | Cumberland Pharmaceuticals Inc. | Treating critically ill patients with intravenous ibuprofen |
| MX2010004974A (es) | 2010-05-04 | 2011-11-23 | Senosiain S A De C V Lab | Combinacion de un aine y un aminoacido. |
| WO2011144766A1 (es) | 2010-05-18 | 2011-11-24 | Spain Pharma, S.A. | Composición farmacéutica de ibuprofeno para inyección |
| JP5639385B2 (ja) | 2010-05-28 | 2014-12-10 | 宏平 澤 | 混練押出装置 |
| US20130225685A1 (en) * | 2010-11-04 | 2013-08-29 | Aft Pharmaceuticals Limited | Combination composition |
| CN102552117B (zh) * | 2010-12-27 | 2014-07-09 | 成都天台山制药有限公司 | 一种含有布洛芬的注射剂及其制备方法 |
| ES2422563B1 (es) * | 2012-03-08 | 2014-06-10 | Farmalider S.A. | Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma |
| US9072710B2 (en) | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
| US20140323505A1 (en) * | 2013-04-25 | 2014-10-30 | Rinsenergy LLC | Oral rinse composition and method to deliver energy supplements |
| CN103720647A (zh) * | 2013-12-16 | 2014-04-16 | 扬子江药业集团广州海瑞药业有限公司 | 一种右旋布洛芬注射液组合物 |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| JP7386080B2 (ja) * | 2016-08-02 | 2023-11-24 | アンバー アイピー リミテッド | 安定なイブプロフェン注射製剤用組成物 |
| SI3996699T1 (sl) | 2019-07-09 | 2023-10-30 | Farmalider, S. A. | Kombinacija ibuprofena in tramadola za lajšanje bolečine |
| CN110693822A (zh) * | 2019-09-29 | 2020-01-17 | 山东罗欣药业集团股份有限公司 | 一种布洛芬注射液及制备方法 |
| KR20210073905A (ko) | 2019-12-11 | 2021-06-21 | (주)휴온스 | 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제 |
| US20230172877A1 (en) * | 2020-03-11 | 2023-06-08 | University Of Virginia Patent Foundation | Metabolites released from apoptotic cells act as novel tissue messengers |
| KR102478284B1 (ko) | 2020-10-28 | 2022-12-15 | 이희엽 | 덱시부프로펜 함유 주사용 액상 조성물 |
| CN112957323B (zh) * | 2021-03-29 | 2022-08-16 | 北京佳诚医药有限公司 | 一种右旋布洛芬注射液 |
| KR20220166738A (ko) | 2021-06-10 | 2022-12-19 | (주)휴온스 | 이부프로펜, 아르기닌 및 염화나트륨을 함유하고, 불순물 저감을 통해 안정성이 개선된 희석 주사용 제제 |
| AR127532A1 (es) * | 2021-12-01 | 2024-02-07 | Quim Luar S R L | Composición farmacéutica que comprende ibuprofeno y arginina |
| GR1010769B (el) * | 2023-07-27 | 2024-09-18 | Ιουλια Κλεωνος Τσετη | Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6393718A (ja) * | 1986-10-07 | 1988-04-25 | Green Cross Corp:The | 注射剤 |
| DE4010536A1 (de) * | 1990-04-02 | 1991-10-10 | Boehringer Mannheim Gmbh | Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure |
| IT1272149B (it) * | 1993-03-26 | 1997-06-11 | Zambon Spa | Composizione farmeceutiche ad attivita' analgesica |
| IT1264857B1 (it) * | 1993-06-21 | 1996-10-17 | Zambon Spa | Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico |
-
2001
- 2001-11-02 DE DE60114249T patent/DE60114249T2/de not_active Expired - Lifetime
- 2001-11-02 JP JP2003541823A patent/JP5185488B2/ja not_active Expired - Fee Related
- 2001-11-02 KR KR1020047005994A patent/KR100851679B1/ko not_active Expired - Fee Related
- 2001-11-02 CN CNB018237649A patent/CN1302771C/zh not_active Expired - Lifetime
- 2001-11-02 ES ES01274674T patent/ES2253326T3/es not_active Expired - Lifetime
- 2001-11-02 EP EP01274674A patent/EP1439830B1/de not_active Expired - Lifetime
- 2001-11-02 WO PCT/US2001/042894 patent/WO2003039532A1/en not_active Ceased
- 2001-11-02 DK DK01274674T patent/DK1439830T3/da active
- 2001-11-02 AU AU2002224475A patent/AU2002224475B2/en not_active Expired
- 2001-11-02 MX MXPA04004024A patent/MXPA04004024A/es active IP Right Grant
- 2001-11-02 AT AT01274674T patent/ATE306917T1/de active
- 2001-11-02 CA CA002462452A patent/CA2462452C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1439830A1 (de) | 2004-07-28 |
| HK1068782A1 (en) | 2005-05-06 |
| WO2003039532A1 (en) | 2003-05-15 |
| KR100851679B1 (ko) | 2008-08-13 |
| AU2002224475B2 (en) | 2008-01-17 |
| DE60114249D1 (de) | 2006-03-02 |
| CN1302771C (zh) | 2007-03-07 |
| JP5185488B2 (ja) | 2013-04-17 |
| JP2005510510A (ja) | 2005-04-21 |
| EP1439830B1 (de) | 2005-10-19 |
| ES2253326T3 (es) | 2006-06-01 |
| DK1439830T3 (da) | 2006-02-13 |
| KR20040063913A (ko) | 2004-07-14 |
| DE60114249T2 (de) | 2006-05-18 |
| CN1585635A (zh) | 2005-02-23 |
| CA2462452C (en) | 2006-07-04 |
| MXPA04004024A (es) | 2004-10-29 |
| CA2462452A1 (en) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE306917T1 (de) | Pharmazeutische zusammensetzung mit 2-(4- isobutylphenyl) propionsäure | |
| FI961059A0 (fi) | Protonipumppuinhibiittoria sisältävä tabletoitu moniyksikköannostusmuoto | |
| DE60236541D1 (de) | Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1 | |
| EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| Murcia-Soler et al. | Artificial neural networks and linear discriminant analysis: a valuable combination in the selection of new antibacterial compounds | |
| EA200400777A1 (ru) | Фармацевтические композиции соединения платины | |
| DE50011582D1 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| CY1115940T1 (el) | Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων | |
| IL140848A (en) | Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate | |
| NO20023551L (no) | Ibuprofen-inneholdende aktivt middel-preparat | |
| IT1264857B1 (it) | Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico | |
| KR970702291A (ko) | 에퀼린의 산 이성질화체로부터 제조된 에퀼린 이중결합 이성질체(Anequilin double bond isomer from the acid isomerization of equilin) | |
| UA74347C2 (uk) | Безводна або майже безводна, стабільна рідка композиція | |
| NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
| DE60236025D1 (de) | Pharmazeutische zusammensetzung enthaltend l-arginin | |
| AU5326098A (en) | Benzofuranacrylic acid derivatives and their use as modulators of RXRS or RARS receptors | |
| EP0647616A4 (de) | Zink-tranexamat derivat. | |
| EA200400707A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| KR970706844A (ko) | 트롬빈 억제제를 함유하는 저장 안정성 수용액상 주입액(A Storage Stable Water Solution for Infusion Containing A Thrombin Inhibitor) | |
| WO2002098843A3 (en) | Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors | |
| EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
| ES8305759A1 (es) | "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona". | |
| BR0307039A (pt) | Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias | |
| KR920016404A (ko) | 신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 | |
| EA200500957A1 (ru) | Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1439830 Country of ref document: EP |